Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

Authors :: Walsh, Thomas J.
Pappas, Peter
Winston, Drew J.
Lazarus, Hillard M.
Petersen, Finn
Raffalli, John
Yanovich, Saul
Stiff, Patrick
Greenberg, Richard
Donowitz, Gerald
Lee, Jeanette
Source :: The New England Journal of Medicine. Jan 24, 2002, Vol. 346 Issue 4, p225, 10 p.
Publication Year :: 2002
Abstract: The antifungal drug voriconazole appears to be as effective as amphotericin B for preventing fungal infections in cancer patients and has fewer side effects. Chemotherapy can damage the immune system, making patients susceptible to infection.

Subjects :: Neutropenia -- Drug therapy
Mycoses -- Prevention
Antifungal agents -- Evaluation

Tools